protein biomarkers
Spanish Startup Mecwins Raises $4.7M to Develop Early Disease Detection Prototypes
The firm said that with the funding it will strengthen its research team and develop new clinical trials to evaluate its high-sensitivity disease detection technology.
University of Liverpool, Bard1 Life Sciences to Evaluate Diabetes Blood Test
The agreement provides Bard1 with the option to license the intellectual property for the development and evaluation of a type 3c diabetes test that uses novel protein biomarkers.
The company, which received CE marking for its high sensitivity troponin I assay and Atellica VTLi Patient-side Immunoassay Analyzer, plans to enter the US market.
Neurodegenerative Disease Testing Firm CND Life Sciences Closes $2.4M Seed Financing Round
The financing will go toward the expansion of the company's laboratory operations and acceleration of the sales and marketing efforts of its Syn-One Test.
The firm anticipates completing the study in about 18 months and then applying for US Food and Drug Administration clearance for its multimodal platform and assays.